Last updated on August 2016

A Double-Blind, Randomized controlled study of Etanercept and Methotrexate in combination or as Monotherapy in subjects with Psoriatic Arthritis


Brief description of study

A Double-Blind, Randomized controlled study of Etanercept and Methotrexate in combination or as Monotherapy in subjects with Psoriatic Arthritis

Detailed Study Description

This study of Etanercept and Methotrexate compared to Etanercept alone and Methotrexate alone will last up to 52 weeks. Qualified participants may receive compensation for study-related travel.

Clinical Study Identifier: TX144789

Find a site near you

Start Over

Metroplex Clinical Research Center

8144 Walnut Hill Lane Suite 810 Dallas, TX USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.